Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study-Reference-Cited by-同舟云学术

Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study

Published:2019-08 Issue:2 Volume:71 Page:313-322
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Haldar Debashis^ORCID,Kern Barbara,Hodson James,Armstrong Matthew James,Adam Rene,Berlakovich Gabriela,Fritz Josef,Feurstein Benedikt,Popp Wolfgang,Karam Vincent^ORCID,Muiesan Paolo,O'Grady John,Jamieson Neville,Wigmore Stephen J.,Pirenne Jacques,Malek-Hosseini Seyed Ali,Hidalgo Ernest,Tokat Yaman,Paul Andreas,Pratschke Johann,Bartels Michael,Trunecka Pavel,Settmacher Utz,Pinzani Massimo^ORCID,Duvoux Christophe,Newsome Philip Noel,Schneeberger Stefan^ORCID

Funder

NIHR Birmingham Biomedical Research Centre

University Hospitals Birmingham NHS Foundation Trust

University of Birmingham

Wellcome Trust

Publisher

Elsevier BV

Subject

Hepatology

Reference37 articles.

1. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants;Lancet,2016

2. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants;Lancet,2016

3. Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

4. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis;Dulai;Hepatology,2017

5. Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the United States;Cholankeril;Clin Gastroenterol Hepatol,2017

Cited by 239 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Waitlist and transplant outcomes in patients with metabolic dysfunction‐associated steatotic liver disease and autoimmune hepatitis;Liver International;2024-09-11

2. FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH;Liver International;2024-09-03

3. S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV);Zeitschrift für Gastroenterologie;2024-09

4. Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study;JHEP Reports;2024-09

5. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09